Prioritizing investments in new vaccines against epidemic infectious diseases: A multi‐criteria decision analysis-Reference-Cited by-同舟云学术

Prioritizing investments in new vaccines against epidemic infectious diseases: A multi‐criteria decision analysis

Published:2019-05 Issue:3-4 Volume:26 Page:153-163
ISSN:1057-9214
Container-title:Journal of Multi-Criteria Decision Analysis
language:en
Short-container-title:J Multi‐Crit Decis Anal

Author:

Gouglas Dimitrios¹²^ORCID,Marsh Kevin³

Affiliation:

1. Norwegian Institute of Public Health Oslo Norway

2. Epidemic Preparedness Innovations Oslo Norway

3. Evidera‐Patient‐Centered Research London UK

Publisher

Wiley

Subject

Strategy and Management,General Decision Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mcda.1683

Reference46 articles.

1. Application of multicriteria decision analysis in health care: a systematic review and bibliometric analysis

2. Optimization of Pharmaceutical R&D Programs and Portfolios

3. Revitalizing portfolio decision-making at Merck Serono S.A. – Geneva

4. Biomedical Advanced Research and Development Authority (BARDA). (2018).The BARDA BAA Medical Countermeasures Acquisition Process. Web Site.https://www.phe.gov/about/amcg/BARDA‐BAA/Pages/barda‐baa‐process.aspxAccessed July 3 2018.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing risks in technological R&D projects with Probability-Impact AHPSort;Annals of Operations Research;2024-06-14

2. A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers;PLOS ONE;2023-04-05

3. Auditing the quality of epidemic decision-making in Somalia: a pilot evaluation;BMJ Open;2023-01

4. Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery;Entrepreneurship and Innovation Policy and the Economy;2023-01-01

5. Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery;SSRN Electronic Journal;2023